BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 21296679)

  • 1. Considerations on photochemical genotoxicity. II: report of the 2009 International Workshop on Genotoxicity Testing Working Group.
    Lynch AM; Guzzie PJ; Bauer D; Gocke E; Itoh S; Jacobs A; Krul CA; Schepky A; Tanaka N; Kasper P
    Mutat Res; 2011 Aug; 723(2):91-100. PubMed ID: 21296679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improvement of in vivo genotoxicity assessment: combination of acute tests and integration into standard toxicity testing.
    Rothfuss A; Honma M; Czich A; Aardema MJ; Burlinson B; Galloway S; Hamada S; Kirkland D; Heflich RH; Howe J; Nakajima M; O'Donovan M; Plappert-Helbig U; Priestley C; Recio L; Schuler M; Uno Y; Martus HJ
    Mutat Res; 2011 Aug; 723(2):108-20. PubMed ID: 21182982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategy for genotoxicity testing--metabolic considerations.
    Ku WW; Bigger A; Brambilla G; Glatt H; Gocke E; Guzzie PJ; Hakura A; Honma M; Martus HJ; Obach RS; Roberts S;
    Mutat Res; 2007 Feb; 627(1):59-77. PubMed ID: 17141553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Follow-up testing of rodent carcinogens not positive in the standard genotoxicity testing battery: IWGT workgroup report.
    Kasper P; Uno Y; Mauthe R; Asano N; Douglas G; Matthews E; Moore M; Mueller L; Nakajima M; Singer T; Speit G;
    Mutat Res; 2007 Feb; 627(1):106-16. PubMed ID: 17123861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of the performance of the 3T3 NRU in vitro phototoxicity assay in the pharmaceutical industry.
    Lynch AM; Wilcox P
    Exp Toxicol Pathol; 2011 Mar; 63(3):209-14. PubMed ID: 20060695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The in vivo comet assay: use and status in genotoxicity testing.
    Brendler-Schwaab S; Hartmann A; Pfuhler S; Speit G
    Mutagenesis; 2005 Jul; 20(4):245-54. PubMed ID: 15899933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategy for genotoxicity testing: hazard identification and risk assessment in relation to in vitro testing.
    Thybaud V; Aardema M; Clements J; Dearfield K; Galloway S; Hayashi M; Jacobson-Kram D; Kirkland D; MacGregor JT; Marzin D; Ohyama W; Schuler M; Suzuki H; Zeiger E;
    Mutat Res; 2007 Feb; 627(1):41-58. PubMed ID: 17126066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing strategies in mutagenicity and genetic toxicology: an appraisal of the guidelines of the European Scientific Committee for Cosmetics and Non-Food Products for the evaluation of hair dyes.
    Kirkland DJ; Henderson L; Marzin D; Müller L; Parry JM; Speit G; Tweats DJ; Williams GM
    Mutat Res; 2005 Dec; 588(2):88-105. PubMed ID: 16326131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo rodent erythrocyte micronucleus assay. II. Some aspects of protocol design including repeated treatments, integration with toxicity testing, and automated scoring.
    Hayashi M; MacGregor JT; Gatehouse DG; Adler ID; Blakey DH; Dertinger SD; Krishna G; Morita T; Russo A; Sutou S
    Environ Mol Mutagen; 2000; 35(3):234-52. PubMed ID: 10737958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommended lists of genotoxic and non-genotoxic chemicals for assessment of the performance of new or improved genotoxicity tests: a follow-up to an ECVAM workshop.
    Kirkland D; Kasper P; Müller L; Corvi R; Speit G
    Mutat Res; 2008 May; 653(1-2):99-108. PubMed ID: 18539078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can light absorption and photostability data be used to assess the photosafety risks in patients for a new drug molecule?
    Henry B; Foti C; Alsante K
    J Photochem Photobiol B; 2009 Jul; 96(1):57-62. PubMed ID: 19443235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the Vitotox and RadarScreen assays for the rapid assessment of genotoxicity in the early research phase of drug development.
    Westerink WM; Stevenson JC; Lauwers A; Griffioen G; Horbach GJ; Schoonen WG
    Mutat Res; 2009 May; 676(1-2):113-30. PubMed ID: 19393335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo erythrocyte micronucleus assay III. Validation and regulatory acceptance of automated scoring and the use of rat peripheral blood reticulocytes, with discussion of non-hematopoietic target cells and a single dose-level limit test.
    Hayashi M; MacGregor JT; Gatehouse DG; Blakey DH; Dertinger SD; Abramsson-Zetterberg L; Krishna G; Morita T; Russo A; Asano N; Suzuki H; Ohyama W; Gibson D;
    Mutat Res; 2007 Feb; 627(1):10-30. PubMed ID: 17157053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of genotoxicity test procedures with Episkin, a reconstructed human skin model: towards new tools for in vitro risk assessment of dermally applied compounds?
    Flamand N; Marrot L; Belaidi JP; Bourouf L; Dourille E; Feltes M; Meunier JR
    Mutat Res; 2006 Jul; 606(1-2):39-51. PubMed ID: 16675293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of the dog as non-rodent test species in the safety testing schedule associated with the registration of crop and plant protection products (pesticides): present status.
    Box RJ; Spielmann H
    Arch Toxicol; 2005 Nov; 79(11):615-26. PubMed ID: 15940470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale of genotoxicity testing of nanomaterials: regulatory requirements and appropriateness of available OECD test guidelines.
    Warheit DB; Donner EM
    Nanotoxicology; 2010 Dec; 4():409-13. PubMed ID: 20925448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compilation and use of genetic toxicity historical control data.
    Hayashi M; Dearfield K; Kasper P; Lovell D; Martus HJ; Thybaud V
    Mutat Res; 2011 Aug; 723(2):87-90. PubMed ID: 20933606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic toxicity assessment: employing the best science for human safety evaluation part III: the comet assay as an alternative to in vitro clastogenicity tests for early drug candidate selection.
    Witte I; Plappert U; de Wall H; Hartmann A
    Toxicol Sci; 2007 May; 97(1):21-6. PubMed ID: 17204584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of published data for top concentration considerations in mammalian cell genotoxicity testing.
    Parry JM; Parry E; Phrakonkham P; Corvi R
    Mutagenesis; 2010 Nov; 25(6):531-8. PubMed ID: 20720196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro genotoxicity test approaches with better predictivity: summary of an IWGT workshop.
    Pfuhler S; Fellows M; van Benthem J; Corvi R; Curren R; Dearfield K; Fowler P; Frötschl R; Elhajouji A; Le Hégarat L; Kasamatsu T; Kojima H; Ouédraogo G; Scott A; Speit G
    Mutat Res; 2011 Aug; 723(2):101-7. PubMed ID: 21473931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.